ATE231142T1 - Cyclopropachromencarbonsäure derivate - Google Patents

Cyclopropachromencarbonsäure derivate

Info

Publication number
ATE231142T1
ATE231142T1 AT95934860T AT95934860T ATE231142T1 AT E231142 T1 ATE231142 T1 AT E231142T1 AT 95934860 T AT95934860 T AT 95934860T AT 95934860 T AT95934860 T AT 95934860T AT E231142 T1 ATE231142 T1 AT E231142T1
Authority
AT
Austria
Prior art keywords
group
carbon atoms
substituted
hydrogen atom
atom
Prior art date
Application number
AT95934860T
Other languages
English (en)
Inventor
Hirokazu Annoura
Atsuko Fukunaga
Toshio Tatsuoka
Yoshiko Horikawa
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE231142T1 publication Critical patent/ATE231142T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AT95934860T 1994-10-21 1995-10-20 Cyclopropachromencarbonsäure derivate ATE231142T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25646894 1994-10-21
JP22536595A JP3993651B2 (ja) 1994-10-21 1995-09-01 シクロプロパクロメンカルボン酸誘導体
PCT/JP1995/002163 WO1996012715A1 (fr) 1994-10-21 1995-10-20 Derives de cyclopropachromenecarboxylate

Publications (1)

Publication Number Publication Date
ATE231142T1 true ATE231142T1 (de) 2003-02-15

Family

ID=26526593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95934860T ATE231142T1 (de) 1994-10-21 1995-10-20 Cyclopropachromencarbonsäure derivate

Country Status (7)

Country Link
US (1) US5843988A (de)
EP (1) EP0787723B1 (de)
JP (1) JP3993651B2 (de)
AT (1) ATE231142T1 (de)
DE (1) DE69529418T2 (de)
ES (1) ES2191063T3 (de)
WO (1) WO1996012715A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19801646A1 (de) * 1998-01-17 1999-07-22 Bayer Ag Substituierte alpha,beta-annellierte Butyrolactone
DE19801647A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte beta,gamma-annellierte Lactone
DE19801636A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte bicyclische Lactone
EP1059090A4 (de) * 1998-03-03 2002-02-27 Yamanouchi Pharma Co Ltd Medikamente gegen hirninfarkt.
GB9823845D0 (en) * 1998-11-02 1998-12-23 Lilly Co Eli Pharmaceutical compounds
AU2241400A (en) 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
GB0007193D0 (en) * 2000-03-25 2000-05-17 Univ Manchester Treatment of movrmrnt disorders
US6660858B2 (en) * 2001-03-28 2003-12-09 Lion Bioscience Ag 2-aminobenzoxazole derivatives and combinatorial libraries thereof
WO2005007096A2 (en) * 2003-07-11 2005-01-27 Merck & Co., Inc. Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
CN101862322A (zh) 2004-07-30 2010-10-20 托伦特药物有限公司 奈必洛尔及其药学可接受盐、制备方法以及奈必洛尔的药物组合物
DE102005011534A1 (de) * 2005-03-10 2006-09-21 Merck Patent Gmbh Chromen-4-on-Derivate
EP2275096A3 (de) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP2258357A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
DE102005062990A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
KR20090064418A (ko) * 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
DK2493871T3 (da) 2009-10-30 2014-11-10 Prestwick Chemical Sas Nye oximderivater samt deres anvendelse som allosteriske modulatorer af metabotropiske glutamatreceptorer
ES2714073T3 (es) * 2014-08-27 2019-05-27 Prexton Therapeutics Sa Nuevo derivado de oxima de cromona y su uso como modulador alostérico de receptores metabotrópicos del glutamato
TN2018000061A1 (en) 2015-08-27 2019-07-08 Prexton Therapeutics Sa Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0723367B2 (ja) * 1986-02-27 1995-03-15 サントリー株式会社 オキサビシクロヘプタン誘導体
CA2037188A1 (en) * 1990-06-06 1991-12-07 Toshio Tatsuoka Agent for treating disorders from cerebral neuro-degeneration
JP3054207B2 (ja) * 1990-06-06 2000-06-19 サントリー株式会社 シクロプロパクロメン誘導体
DE4018468A1 (de) * 1990-06-08 1991-12-12 Ultrakust Electronic Gmbh Verfahren und vorrichtung zur entnahme einer repraesentativen milchprobe

Also Published As

Publication number Publication date
EP0787723B1 (de) 2003-01-15
US5843988A (en) 1998-12-01
WO1996012715A1 (fr) 1996-05-02
JPH08169884A (ja) 1996-07-02
JP3993651B2 (ja) 2007-10-17
EP0787723A1 (de) 1997-08-06
EP0787723A4 (de) 1998-02-04
DE69529418D1 (de) 2003-02-20
ES2191063T3 (es) 2003-09-01
DE69529418T2 (de) 2003-08-14

Similar Documents

Publication Publication Date Title
ATE231142T1 (de) Cyclopropachromencarbonsäure derivate
DE69206820D1 (de) 1,3-Dihydro-2H-Imidano 4,5-b-quinolin-2-ein Derivate als Phosphodiestenase Hemmer
MY131297A (en) Herbicides
UA42684C2 (uk) Похідні бензимідазолону та їх фізіологічно прийнятні кислотно-адитивні солі
NZ509045A (en) Intermediates in the formation of antivirally active heterocyclic azahexane derivatives
DK0870768T3 (da) Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler
MY110447A (en) New herbicides
FI942635A0 (fi) Piperatsiinijohdannaiset 5HT1A-antagonisteina
DK0572093T3 (da) Herbicide 2,6-substituerede pyridiner
DE69918695D1 (de) Sauerstoffhaltige heterocyclische verbindungen
ATE144511T1 (de) Tetrahydrobenzimidazol-derivate
PE34996A1 (es) Nuevo derivado de pirrocarbazol
DE69733308D1 (de) Aktivsauerstoffaufnehmer enthaltende pterinderivate
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
DE69512816D1 (de) Oxopyridylchinoxalin Derivate
DE60016384D1 (de) Chondrogonese promotoren und indolin-2-on derivate
ATE248598T1 (de) Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate
ATE504572T1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
MX9202178A (es) Nuevos derivados de 2-piperacinil bencimidazol.
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
ATE105565T1 (de) Pradimicinderivate.
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
ES2084763T3 (es) 4-(4- o 6-(2-trifluormetil piridinil))1-piperazinilalquilo lactamas sustituidas.
DE69303847T2 (de) Indolderivate
DE69231244T2 (de) Pyrazolothiazolopyrimidin-derivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties